Massimo Tempestilli

1.0k total citations
35 papers, 546 citations indexed

About

Massimo Tempestilli is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Massimo Tempestilli has authored 35 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 13 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Massimo Tempestilli's work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (11 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Massimo Tempestilli is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (11 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Massimo Tempestilli collaborates with scholars based in Italy, United States and France. Massimo Tempestilli's co-authors include Chiara Agrati, Leopoldo Paolo Pucillo, Federico Martini, Stefania Notari, Fabrizio Poccia, Cristiana Gioia, Andrea Antinori, Emanuele Nicastri, Alessandra Sacchi and Pasquale Narciso and has published in prestigious journals such as PLoS ONE, Neuroscience and The Journal of Infectious Diseases.

In The Last Decade

Massimo Tempestilli

34 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Tempestilli Italy	14	188	158	149	92	90	35	546
Sima S. Toussi United States	14	342 1.8×	135 0.9×	213 1.4×	121 1.3×	99 1.1×	26	776
Fulvio Erba Italy	15	263 1.4×	104 0.7×	89 0.6×	107 1.2×	221 2.5×	31	559
Mario Sarcletti Austria	15	226 1.2×	97 0.6×	191 1.3×	70 0.8×	247 2.7×	33	616
Frédéric Théodoro France	15	375 2.0×	143 0.9×	229 1.5×	85 0.9×	422 4.7×	25	723
Madison Schank United States	18	162 0.9×	236 1.5×	174 1.2×	245 2.7×	155 1.7×	30	714
Joanna Peterkin United States	12	258 1.4×	72 0.5×	48 0.3×	106 1.2×	189 2.1×	17	553
Nanci Hawley‐Foss Canada	10	298 1.6×	167 1.1×	160 1.1×	68 0.7×	341 3.8×	19	588
Nhut Le United States	16	289 1.5×	174 1.1×	110 0.7×	107 1.2×	351 3.9×	24	588
Ronald B. Moss United States	15	219 1.2×	258 1.6×	187 1.3×	114 1.2×	360 4.0×	39	729

Countries citing papers authored by Massimo Tempestilli

Since Specialization

Citations

This map shows the geographic impact of Massimo Tempestilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Tempestilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Tempestilli more than expected).

Fields of papers citing papers by Massimo Tempestilli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Tempestilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Tempestilli. The network helps show where Massimo Tempestilli may publish in the future.

Co-authorship network of co-authors of Massimo Tempestilli

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Tempestilli. A scholar is included among the top collaborators of Massimo Tempestilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Tempestilli. Massimo Tempestilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tartaglia, Eleonora, Francesco Messina, Andrea Coppola, et al.. (2025). Vδ2 T-cells response in people with Mpox infection: a three-month longitudinal assessment. Emerging Microbes & Infections. 14(1). 2455585–2455585. 2 indexed citations

Tempestilli, Massimo, Annalisa Mondi, Antonio D’Avolio, et al.. (2023). Pharmacokinetics of tecovirimat in subjects with Mpox. International Journal of Antimicrobial Agents. 63(2). 107068–107068. 3 indexed citations

Cusato, Jessica, Massimo Tempestilli, Andrea Calcagno, et al.. (2021). Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz. Nutrients. 13(10). 3571–3571. 4 indexed citations

Mastrorosa, Ilaria, Massimo Tempestilli, Stefania Notari, et al.. (2021). Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected Persons. European Journal of Drug Metabolism and Pharmacokinetics. 47(1). 135–142. 1 indexed citations

Bellagamba, Rita, Maria Letizia Giancola, Chiara Tommasi, et al.. (2019). Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment. AIDS. 33(3). 493–502. 8 indexed citations

Notari, Stefania, Massimo Tempestilli, Raffaella Libertone, et al.. (2017). UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients. Journal of Chromatography B. 1073. 183–190. 34 indexed citations

Tempestilli, Massimo, Ilaria Mastrorosa, Stefania Notari, et al.. (2017). Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world. Journal of Antimicrobial Chemotherapy. 73(1). 160–164. 2 indexed citations

Daker, Sary El, Alessandra Sacchi, Massimo Tempestilli, et al.. (2015). Granulocytic Myeloid Derived Suppressor Cells Expansion during Active Pulmonary Tuberculosis Is Associated with High Nitric Oxide Plasma Level. PLoS ONE. 10(4). e0123772–e0123772. 58 indexed citations

Chinello, Pierangelo, Stefania Cicalini, Simona Pichini, et al.. (2015). Sildenafil and bosentan plasma concentrations in a human immunodeficiency virus-infected patient with pulmonary arterial hypertension treated with ritonavir-boosted protease inhibitor. Infectious Disease Reports. 7(1). 5822–5822. 6 indexed citations

10.

Tempestilli, Massimo, Federica Elisei, Eleonora Cimini, et al.. (2014). Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoprotein. Journal of Antimicrobial Chemotherapy. 69(7). 1760–1766. 5 indexed citations

11.

Tempestilli, Massimo, Elisa Gentilotti, Chiara Tommasi, et al.. (2013). Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors. International Immunopharmacology. 16(4). 492–497. 13 indexed citations

12.

Chinello, Pierangelo, Stefania Cicalini, Simona Pichini, et al.. (2012). Sildenafil Plasma Concentrations in Two HIV Patients with Pulmonary Hypertension Treated with Ritonavir-Boosted Protease Inhibitors. Current HIV Research. 10(2). 162–164. 15 indexed citations

13.

Nicastri, Emanuele, Jelena Ivanović, Fabrizio Signore, et al.. (2012). Antiretroviral Therapeutic Drug Monitoring in HIV-Infected Pregnant Women: Maternal Immunovirological Outcome at Delivery and During the 18 Month Follow-Up Period. Current HIV Research. 10(7). 606–613. 3 indexed citations

14.

Notari, Stefania, Carmine Mancone, Manuel Sergi, et al.. (2010). Determination of antituberculosis drug concentration in human plasma by MALDI‐TOF/TOF. IUBMB Life. 62(5). 387–393. 15 indexed citations

15.

Tommasi, Chiara, Francesca Ceccherini‐Silberstein, Roberta D’Arrigo, et al.. (2010). Use of novel antiretroviral agents in rescue regimens: A case of early virological failure to raltegravir. Scandinavian Journal of Infectious Diseases. 42(3). 237–239. 1 indexed citations

16.

Poccia, Fabrizio, Cristiana Gioia, Federico Martini, et al.. (2009). Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vγ9Vδ2 T cells. AIDS. 23(5). 555–565. 50 indexed citations

17.

Notari, Stefania, Chiara Tommasi, Emanuele Nicastri, et al.. (2009). Simultaneous determination of maraviroc and raltegravir in human plasma by HPLC‐UV. IUBMB Life. 61(4). 470–475. 23 indexed citations

18.

Ivanović, Jelena, Emanuele Nicastri, Maurizio M. Anceschi, et al.. (2009). Transplacental Transfer of Antiretroviral Drugs and Newborn Birth Weight in HIV-Infected Pregnant Women. Current HIV Research. 7(6). 620–625. 30 indexed citations

19.

Sacchi, Alessandra, Massimo Tempestilli, Federica Turchi, et al.. (2008). CD3ζ Down‐Modulation May Explain Vγ9Vδ2 T Lymphocyte Anergy in HIV‐Infected Patients. The Journal of Infectious Diseases. 199(3). 432–436. 9 indexed citations

20.

Nisii, Carla, Massimo Tempestilli, Chiara Agrati, et al.. (2005). Accumulation of dysfunctional effector CD8+T cells in the liver of patients with chronic HCV infection. Journal of Hepatology. 44(3). 475–483. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact